Document is current
Any future updates will be listed below
-
Authors
Kretschmer, Lydia
Ruhnke, Leo
Schliemann, Christoph
Fransecky, Lars
Steffen, Björn
Kaufmann, Martin
Burchert, Andreas
Schmid, Christoph
Hanoun, Maher
Sauer, Tim
Metzeler, Klaus H.
Schäfer-Eckart, Kerstin
Hänel, Mathias
Crysandt, Martina
Jäger, Paul
Krause, Stefan W.
Dierks, Christine
Klein, Stefan
Maguire, Nadia
Frenzel, Lukas P.
Bücklein, Veit L.
Blau, Wolfgang
Kaiser, Ulrich
Wegehenkel, Kai
Höllein, Alexander
Seggewiss-Bernhardt, Ruth
Markgraf, Wenke
Fiebig, Frank
Harig, Anna
Schmidt-Brücken, Katharina
Thiede, Christian
Middeke, Jan Moritz
Dillon, Richard
Baldus, Claudia D.
Serve, Hubert
Spiekermann, Karsten
Hiddemann, Wolfgang
Schlenk, Richard F.
Müller-Tidow, Carsten
Bornhäuser, Martin
Röllig, Christoph
-
Funding
Funding for this research was provided by:
Universitätsklinikum Carl Gustav Carus Dresden an der Technischen Universität Dresden
- License Information
-
More Information
Article History
Received: 20 April 2025
Accepted: 26 June 2025
First Online: 9 July 2025
Declarations
:
: The study (NCT05904106) is conducted in accordance with the Declaration of Helsinki and approved by the institutional bioethics review committee of the Technische Universität (TU) Dresden (EK13012023).
: LK: Travel grants: AbbVie Inc., Beigene, Jazz Pharmaceuticals, Johnson & Johnson. LR: Travel grants: BeiGene, Inc., AbbVie Inc., Jazz Pharmaceuticals, Johnson & Johnson, Neovii Pharmaceuticals; Consultancy und Honoraria: Actitrexx GmbH, AbbVie Inc.; Research Funding: AbbVie Inc. CR: Consultancy und Honoraria: AbbVie Inc., Amgen, Astellas, Bristol-Meyer-Squibb, Daiichi Sankyo, Jazz Pharmaceuticals, J&J, Novartis, Otsuka, Pfizer, Roche, Servier; Research Funding: AbbVie Inc., Astellas, Novartis, Pfizer. CS: Honoraria/Advisory Boards: AbbVie Inc., Astellas, AstraZeneca, Bristol-Meyer-Squibb, Laboratories Delbert, Jazz Pharmaceuticals, Novartis, Otsuka, Pfizer, Roche; Research support (institutional): Jazz Pharmaceuticals; Travel grants: AbbVie Inc., Bristol-Meyer-Squibb, Jazz Pharmaceuticals, Pfizer. LF: Consultancy und Honoraria: AbbVie Inc.; Research Funding: AbbVie Inc. RSB: Honoraria: AbbVie Inc., Amgen, Astra Zeneca, Beigene, Bristol-Meyer-Squibb, Celgene, Eusa Pharma, IPSEN, Merck, MSD, Novartis, Pfizer, Roche; Membership on an entity’s Board of Directors or advisory committees: AbbVie Inc., Beigene, MSD, Novartis, Roche.
